{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:47:29Z","timestamp":1787737649405,"version":"build-2784847793"},"update-to":[{"DOI":"10.1002\/14651858.cd005647.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T00:00:00Z","timestamp":1532476800000}}],"reference-count":97,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005647.pub3","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T22:15:57Z","timestamp":1532556957000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Treatment for HIV-associated cryptococcal meningitis"],"prefix":"10.1002","volume":"2018","author":[{"given":"Mark W","family":"Tenforde","sequence":"first","affiliation":[{"name":"University of Washington School of Medicine; Division of Allergy and Infectious Diseases; 1959 Pacific Street NE Seattle USA WA 98195"},{"name":"University of Washington School of Public Health; Department of Epidemiology; Seattle USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne E","family":"Shapiro","sequence":"additional","affiliation":[{"name":"University of Washington School of Medicine; Division of Allergy and Infectious Diseases; 1959 Pacific Street NE Seattle USA WA 98195"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Rouse","sequence":"additional","affiliation":[{"name":"Johns Hopkins Bloomberg School of Public Health; Department of Epidemiology; 615 N. Wolfe Street Baltimore Maryland USA 21205"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph N","family":"Jarvis","sequence":"additional","affiliation":[{"name":"London School of Hygiene & Tropical Medicine; Faculty of Infectious and Tropical Diseases; Keppel Street London UK WC1E 7HT"},{"name":"Botswana Harvard AIDS Institute Partnership; Gaborone Botswana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjing","family":"Li","sequence":"additional","affiliation":[{"name":"Johns Hopkins Bloomberg School of Public Health; Department of Epidemiology; 615 N. Wolfe Street Baltimore Maryland USA 21205"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Eshun-Wilson","sequence":"additional","affiliation":[{"name":"Stellenbosch University; Centre for Evidence Based Health Care, Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences; Francie van Zyl Drive, Tygerberg, 7505, Parow Cape Town Western Cape South Africa 7505"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Ford","sequence":"additional","affiliation":[{"name":"World Health Organization; Department of HIV & Global Hepatitis Programme; Geneva Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,7,25]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD005647.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMoa1509024","article-title":"Adjunctive dexamethasone in HIV-associated cryptococcal meningitis","volume":"374","author":"Beardsley","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"9423","key":"10.1002\/14651858.CD005647.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","article-title":"Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial","volume":"363","author":"Brouwer","year":"2004","journal-title":"Lancet"},{"issue":"14","key":"10.1002\/14651858.CD005647.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1110404","article-title":"Combination antifungal therapy for cryptococcal meningitis","volume":"368","author":"Day","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD005647.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/QAD.0b013e328354b419","article-title":"A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis","volume":"26","author":"Jackson","year":"2012","journal-title":"AIDS"},{"issue":"9","key":"10.1002\/14651858.CD005647.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/QAD.0b013e3283536a93","article-title":"Adjunctive interferon-\u03b3 immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial","volume":"26","author":"Jarvis","year":"2012","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD005647.pub3-BIB0006|cit6","unstructured":"Jarvis JN Leeme TB Molefi M Chofle AA Bidwell G Tsholo K Short course high-dose liposomal amphotericin B for HIV-associated cryptococcal meningitis: a phase-II randomised controlled trial Clinical Infectious Diseases 10.1093\/cid\/ciy515"},{"issue":"12","key":"10.1002\/14651858.CD005647.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/00002030-199712000-00010","article-title":"Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis","volume":"11","author":"Leenders","year":"1997","journal-title":"AIDS"},{"issue":"3","key":"10.1002\/14651858.CD005647.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/QAD.0b013e328333c005","article-title":"Histopathology of the arachnoid granulations and brain in HIV-associated cryptococcal meningitis: correlation with cerebrospinal fluid pressure","volume":"24","author":"Loyse","year":"2010","journal-title":"AIDS"},{"issue":"6","key":"10.1002\/14651858.CD005647.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1086\/516372","article-title":"Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS","volume":"26","author":"Mayanja-Kizza","year":"1998","journal-title":"Clinical Infectious Diseases"},{"issue":"11","key":"10.1002\/14651858.CD005647.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1710922","article-title":"Antifungal combinations for treatment of cryptococcal meningitis in Africa","volume":"378","author":"Molloy","year":"2018","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD005647.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/649861","article-title":"Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi","volume":"50","author":"Nussbaum","year":"2010","journal-title":"Clinical Infectious Diseases"},{"issue":"12","key":"10.1002\/14651858.CD005647.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1086\/599112","article-title":"A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis","volume":"48","author":"Pappas","year":"2009","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD005647.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","article-title":"Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group","volume":"337","author":"Horst","year":"1997","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD005647.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1086\/588792","article-title":"High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial","volume":"47","author":"Bicanic","year":"2008","journal-title":"Clinical Infectious Diseases"},{"issue":"8","key":"10.1002\/14651858.CD005647.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/cid\/cit019","article-title":"Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis","volume":"56","author":"Bisson","year":"2013","journal-title":"Clinical Infectious Diseases"},{"issue":"26","key":"10.1002\/14651858.CD005647.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1312884","article-title":"Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis","volume":"370","author":"Boulware","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD005647.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJM199102283240902","article-title":"A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome","volume":"324","author":"Bozzette","year":"1991","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD005647.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1128\/AAC.01188-06","article-title":"Oral versus intravenous flucytosine in patients with human immunodeficiency virus-associated cryptococcal meningitis","volume":"51","author":"Brouwer","year":"2007","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD005647.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1086\/338154","article-title":"A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand","volume":"32","author":"Chariyalertsak","year":"2002","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD005647.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1468-1293.2004.00201.x","article-title":"A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency","volume":"5","author":"Chetchotisakd","year":"2004","journal-title":"HIV Medicine"},{"issue":"7","key":"10.1002\/14651858.CD005647.pub3-BIB0021|cit21","first-page":"416","article-title":"Comparison of amphotericin B, flucytosine and itraconazole with amphotericin B and flucytosine in the treatment of cryptococcal meningitis in AIDS","volume":"80","author":"Chotmongkol","year":"1997","journal-title":"Journal of the Medical Association of Thailand"},{"issue":"1","key":"10.1002\/14651858.CD005647.pub3-BIB0022|cit22","first-page":"170","article-title":"Initial treatment of cryptococcal meningitis in AIDS","volume":"36","author":"Chotmongkol","year":"2005","journal-title":"Southeast Asian Journal of Tropical Medicine and Public Health"},{"issue":"2","key":"10.1002\/14651858.CD005647.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00002030-199202000-00007","article-title":"Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis","volume":"6","author":"Gans","year":"1992","journal-title":"AIDS"},{"issue":"2","key":"10.1002\/14651858.CD005647.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1086\/653606","article-title":"Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety","volume":"51","author":"Hamill","year":"2010","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD005647.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/0022-3859.65276","article-title":"Liposomal amphotericin B (Fungisome) for the treatment of cryptococcal meningitis in HIV\/AIDS patients in India: a multicentric, randomized controlled trial","volume":"56","author":"Jadhav","year":"2010","journal-title":"Journal of Postgraduate Medicine"},{"issue":"3","key":"10.1002\/14651858.CD005647.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/clinids\/23.3.556","article-title":"Randomized comparison of amphotericin B deoxycholate dissolved in dextrose or Intralipid for the treatment of AIDS-associated cryptococcal meningitis","volume":"23","author":"Joly","year":"1996","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD005647.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jac\/38.1.117","article-title":"Amphotericin B in a lipid emulsion for the treatment of cryptococcal meningitis in AIDS patients","volume":"38","author":"Joly","year":"1996","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"3","key":"10.1002\/14651858.CD005647.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.7326\/0003-4819-113-3-183","article-title":"Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial","volume":"113","author":"Larsen","year":"1990","journal-title":"Annals of Internal Medicine"},{"issue":"11","key":"10.1002\/14651858.CD005647.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1086\/652652","article-title":"Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa","volume":"50","author":"Makadzange","year":"2010","journal-title":"Clinical Infectious Diseases"},{"issue":"9983","key":"10.1002\/14651858.CD005647.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(15)60164-7","article-title":"Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial","volume":"385","author":"Mfinanga","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD005647.pub3-BIB0031|cit31","first-page":"293","article-title":"The efficacy of fluconazole 600 mg\/day versus itraconazole 600 mg\/day as consolidation therapy of cryptococcal meningitis in AIDS patients","volume":"86","author":"Mootsikapun","year":"2003","journal-title":"Journal of the Medical Association of Thailand"},{"issue":"5","key":"10.1002\/14651858.CD005647.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1086\/342299","article-title":"A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis","volume":"36","author":"Newton","year":"2002","journal-title":"Clinical Infectious Diseases"},{"issue":"12","key":"10.1002\/14651858.CD005647.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1086\/420829","article-title":"Recombinant interferon-gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis","volume":"189","author":"Pappas","year":"2004","journal-title":"Journal of Infectious Diseases"},{"issue":"12","key":"10.1002\/14651858.CD005647.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM199203193261203","article-title":"A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group","volume":"326","author":"Powderly","year":"1992","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD005647.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1056\/NEJM199503163321102","article-title":"A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group","volume":"332","author":"Powderly","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD005647.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S1473-3099(16)00074-8","article-title":"Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study","volume":"16","author":"Rhein","year":"2016","journal-title":"Lancet Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD005647.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM199201093260202","article-title":"Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group","volume":"326","author":"Saag","year":"1992","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD005647.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/515110","article-title":"A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group","volume":"28","author":"Saag","year":"1999","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD005647.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/clinids\/22.2.315","article-title":"Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS","volume":"22","author":"Sharkey","year":"1996","journal-title":"Clinical Infectious Diseases"},{"issue":"10","key":"10.1002\/14651858.CD005647.pub3-BIB0040|cit40","first-page":"1677","article-title":"Comparison of one week with two week regimens of amphotericin B both followed by fluconazole in the treatment of cryptococcal meningitis among AIDS patients","volume":"89","author":"Tansuphaswadikul","year":"2006","journal-title":"Journal of the Medical Association of Thailand"},{"issue":"10","key":"10.1002\/14651858.CD005647.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1080\/00365540701383147","article-title":"Alternate-day versus once-daily administration of amphotericin B in the treatment of cryptococcal meningitis: a randomized controlled trial","volume":"39","author":"Techapornroong","year":"2007","journal-title":"Scandinavian Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD005647.pub3-BIB0042|cit42","first-page":"OC14","article-title":"Combination versus monotherapy for the treatment of HIV associated cryptococcal meningitis","volume":"9","author":"Vaidhya","year":"2015","journal-title":"Journal of Clinical and Diagnostic Research"},{"issue":"10","key":"10.1002\/14651858.CD005647.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/374849","article-title":"Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study","volume":"36","author":"Vibhagool","year":"2003","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD005647.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s15010-017-1059-3","article-title":"Clinical evaluation of the antifungal effect of sertraline in the treatment of cryptococcal meningitis in HIV patients: a single Mexican center experience","volume":"46","author":"Villanueva-Lozano","year":"2018","journal-title":"Infection"},{"key":"10.1002\/14651858.CD005647.pub3-BIB0045|cit45","unstructured":"ISRCTN72509687 High dose AMBISOME on a fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa www.isrctn.com\/ISRCTN72509687"},{"key":"10.1002\/14651858.CD005647.pub3-BIB0046|cit46","unstructured":"NCT00885703 High-dose fluconazole for the treatment of cryptococcal meningitis in HIV-infected individuals (HiFLAC) clinicaltrials.gov\/ct2\/show\/NCT00885703"},{"key":"10.1002\/14651858.CD005647.pub3-BIB0047|cit47","unstructured":"NCT01802385 Adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis (ASTRO-CM) clinicaltrials.gov\/ct2\/show\/NCT01802385"},{"key":"10.1002\/14651858.CD005647.pub3-BIB0048|cit48","unstructured":"Anderegg N Kirk O on behalf of IeDEA-Global Adults and COHERE Immunodeficiency at the start of combination antiretroviral therapy in low-, middle- and high-income countries 9th International AIDS Society Conference on HIV Science; 2017 July 23-26; Paris, France 2017"},{"issue":"2","key":"10.1002\/14651858.CD005647.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"ofu070","DOI":"10.1093\/ofid\/ofu070","article-title":"Standardized electrolyte supplementation and fluid management improves survival during amphotericin therapy for cryptococcal meningitis in resource-limited settings","volume":"1","author":"Bahr","year":"2014","journal-title":"Open Forum Infectious Diseases"},{"issue":"8","key":"10.1002\/14651858.CD005647.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1086\/507895","article-title":"Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution","volume":"43","author":"Bicanic","year":"2006","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD005647.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/518607","article-title":"Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole","volume":"45","author":"Bicanic","year":"2007","journal-title":"Clinical Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD005647.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/QAD.0b013e32832605fe","article-title":"Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures","volume":"23","author":"Bicanic","year":"2009","journal-title":"AIDS"},{"issue":"12","key":"10.1002\/14651858.CD005647.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1128\/AAC.01698-15","article-title":"Toxicity of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated cryptococcal meningitis","volume":"59","author":"Bicanic","year":"2015","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD005647.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3201\/eid2001.130906","article-title":"Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast","volume":"20","author":"Boulware","year":"2014","journal-title":"Emerging Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD005647.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"ofv010","DOI":"10.1093\/ofid\/ofv010","article-title":"Comparative effectiveness of induction therapy for human immunodeficiency virus-associated cryptococcal meningitis: a network meta-analysis","volume":"2","author":"Campbell","year":"2015","journal-title":"Open Forum Infectious Diseases"},{"issue":"10","key":"10.1002\/14651858.CD005647.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1002\/14651858.CD005647.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/313992","article-title":"Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group","volume":"31","author":"Chen","year":"2000","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD005647.pub3-BIB0058|cit58","unstructured":"CINeMA Confidence in Network Meta-Analysis [Software] Institute of Social and Preventive Medicine, University of Bern 2017. Available from cinema.ispm.ch"},{"key":"10.1002\/14651858.CD005647.pub3-BIB0059|cit59","unstructured":"U.S. Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases Division of AIDS Division of AIDS (DAIDS) table for grading the severity of adult and pediatric adverse events, Version 2.0 rsc.tech-res.com\/docs\/default-source\/safety\/daids_ae_grading_table_v2_nov2014.pdf"},{"issue":"7-8","key":"10.1002\/14651858.CD005647.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD005647.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00002030-200402200-00024","article-title":"Epidemiology of HIV-associated cryptococcosis in France (1985-2001): comparison of the pre- and post-HAART eras","volume":"18","author":"Dromer","year":"2004","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD005647.pub3-BIB0062|cit62","unstructured":"Clavirate Analytics EndNote July 2013"},{"key":"10.1002\/14651858.CD005647.pub3-BIB0063|cit63","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD005647.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Research Synthesis Methods"},{"issue":"5","key":"10.1002\/14651858.CD005647.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/cid\/cit794","article-title":"Determinants of mortality in a combined cohort of 501 patients with HIV-associated cryptococcal meningitis: implications for improving outcomes","volume":"58","author":"Jarvis","year":"2014","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD005647.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"e00725","DOI":"10.1128\/mBio.00725-13","article-title":"Efficacy of an abbreviated induction regimen of amphotericin B deoxycholate for cryptococcal meningoencephalitis: 3 days of therapy is equivalent to 14 days","volume":"5","author":"Livermore","year":"2014","journal-title":"mBio"},{"issue":"12","key":"10.1002\/14651858.CD005647.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1086\/593194","article-title":"Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda","volume":"47","author":"Longley","year":"2008","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD005647.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/QAD.0b013e328333c005","article-title":"Histopathology of the arachnoid granulations and brain in HIV-associated cryptococcal meningitis: correlation with cerebrospinal fluid pressure","volume":"24","author":"Loyse","year":"2010","journal-title":"AIDS"},{"issue":"11","key":"10.1002\/14651858.CD005647.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1093\/jac\/dkt221","article-title":"Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal","volume":"68","author":"Loyse","year":"2013","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"7","key":"10.1002\/14651858.CD005647.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1473-3099(13)70078-1","article-title":"Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries","volume":"13","author":"Loyse","year":"2013","journal-title":"Lancet Infectious Diseases"},{"key":"10.1002\/14651858.CD005647.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1198\/016214505000001302","article-title":"Assessing evidence inconsistency in mixed treatment comparisons","volume":"101","author":"Lu","year":"2006","journal-title":"Journal of the American Statistical Association"},{"issue":"2","key":"10.1002\/14651858.CD005647.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/QAI.0000000000000147","article-title":"Cryptococcal meningitis management in Tanzania with strict schedule of serial lumber punctures using intravenous tubing sets: an operational research study","volume":"66","author":"Meda","year":"2014","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"4","key":"10.1002\/14651858.CD005647.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/13693780701851695","article-title":"Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis","volume":"46","author":"Milefchik","year":"2008","journal-title":"Medical Mycology"},{"key":"10.1002\/14651858.CD005647.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD005647.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/clinids\/24.2.131","article-title":"Cryptococcal meningitis in Durban, South Africa: a comparison of clinical features, laboratory findings, and outcome for human immunodeficiency virus (HIV)-positive and HIV-negative patients","volume":"24","author":"Moosa","year":"1997","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD005647.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jinf.2011.10.014","article-title":"Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis","volume":"64","author":"Muzoora","year":"2012","journal-title":"Journal of Infection"},{"issue":"3","key":"10.1002\/14651858.CD005647.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD005647.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"e56269","DOI":"10.1371\/journal.pone.0056269","article-title":"Epidemiology of cryptococcal meningitis in the US: 1997-2009","volume":"8","author":"Pyrgos","year":"2013","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1002\/14651858.CD005647.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infectious Diseases"},{"key":"10.1002\/14651858.CD005647.pub3-BIB0080|cit80","unstructured":"Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"11","key":"10.1002\/14651858.CD005647.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/cid\/ciu596","article-title":"The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis","volume":"59","author":"Rolfes","year":"2014","journal-title":"Clinical Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD005647.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"e67311","DOI":"10.1371\/journal.pone.0067311","article-title":"A prospective longitudinal study of the clinical outcomes of cryptococcal meningitis following treatment induction with 800 mg oral fluconazole in Blantyre, Malawi","volume":"8","author":"Rothe","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1002\/14651858.CD005647.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD005647.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"e99682","DOI":"10.1371\/journal.pone.0099682","article-title":"Evaluating the quality of evidence from a network meta-analysis","volume":"9","author":"Salanti","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1002\/14651858.CD005647.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-2334-6-118","article-title":"Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg\/day or 400 mg\/day of fluconazole","volume":"6","author":"Schaars","year":"2006","journal-title":"BMC Infectious Diseases"},{"issue":"8","key":"10.1002\/14651858.CD005647.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S1473-3099(16)30145-1","article-title":"Changing epidemiology of HIV-associated cryptococcosis in sub-Saharan Africa","volume":"16","author":"Scriven","year":"2016","journal-title":"Lancet Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD005647.pub3-BIB0087|cit87","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005647.pub2","article-title":"Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings","author":"Sloan","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005647.pub3-BIB0088|cit88","unstructured":"StataCorp Stata June 2013"},{"issue":"2","key":"10.1002\/14651858.CD005647.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/jac\/46.2.171","article-title":"Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions","volume":"46","author":"Vermes","year":"2000","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD005647.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1536867X1101100206","article-title":"Multivariate random-effects meta-regression: updates to mvmeta","volume":"11","author":"White","year":"2011","journal-title":"Stata Journal"},{"issue":"2","key":"10.1002\/14651858.CD005647.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jrsm.1045","article-title":"Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression","volume":"3","author":"White","year":"2012","journal-title":"Research Synthesis Methods"},{"issue":"4","key":"10.1002\/14651858.CD005647.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/1536867X1501500403","article-title":"Network meta-analysis","volume":"15","author":"White","year":"2015","journal-title":"Stata Journal"},{"key":"10.1002\/14651858.CD005647.pub3-BIB0093|cit93","unstructured":"World Health Organization Rapid advice: diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children www.who.int\/hiv\/pub\/cryptococcal_disease2011\/en\/"},{"key":"10.1002\/14651858.CD005647.pub3-BIB0094|cit94","unstructured":"World Health Organization Guidelines for the diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children www.who.int\/hiv\/pub\/guidelines\/cryptococcal-disease\/en\/"},{"issue":"7","key":"10.1002\/14651858.CD005647.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1128\/AAC.00212-12","article-title":"The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections","volume":"56","author":"Zhai","year":"2012","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD005647.pub3-BIB0096|cit96","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005647","article-title":"Treatment of acute cryptococcal meningitis in HIV-infected adults in resource-limited settings","author":"Sloan","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD005647.pub3-BIB0097|cit97","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005647.pub2","article-title":"Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings","author":"Sloan","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD005647.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T01:48:40Z","timestamp":1662169720000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005647.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Infectious Diseases Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,7,25]]},"references-count":97,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005647.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,25]]}}}